Virax Biolabs Group Limited (NASDAQ:VRAX) IPO
IPO
Priced at US$5.00 a share on Jul 20, 2022.
- Price
- US$5.00 a share
- Shares offered
- 3,294,784 ordinary shares · 1,350,000 from the company and 1,944,784 from selling shareholders
- Offering size
- US$6.8 million
- Listing
- VRAX on the Nasdaq Capital Market
- Underwriters
- BOUSTEAD SECURITIES, LLC, VALUABLE CAPITAL LIMITED · In the order on the cover
- Shares delivered
- On or about Jul 25, 2022
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Dec 27, 2021 |
| Filed publicly | Mar 18, 2022 |
| Amended 6 times | Newest Jun 27, 2022 |
| Shares registered with an exchange | Jun 30, 2022 |
| Declared effective by the SEC | Jun 30, 2022 |
| Final prospectus, with the price | Jul 21, 2022 |
Filings
From the cover of the final prospectus (424B4) filed Jul 21, 2022